Desvenlafaxine 50 mg/1 (Desvenlafaxine TABLET, FILM COATED, EXTENDED RELEASE) 50 mg/1

Desvenlafaxine 50 mg is an extended-release tablet used for managing mood disorders. This medication is designed to provide consistent relief throughout the day.

Strength

50 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0054-0400-13)

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Desvenlafaxine 50 mg is commonly used to help manage symptoms of mood disorders. It works by affecting certain chemicals in the brain that may be unbalanced in people with these conditions. This medication is often prescribed to help improve mood and reduce symptoms of depression.

Side Effects

Desvenlafaxine 50 mg may cause common side effects such as nausea, dizziness, and fatigue. Some users may also experience dry mouth or insomnia. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

It is important to handle Desvenlafaxine 50 mg with care. Always follow the instructions provided by your healthcare professional. Do not crush or chew the extended-release tablets, as this can affect the way the medication is released into your system.

Avoid Interactions

Desvenlafaxine 50 mg may interact with other medications, including those that affect serotonin levels. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with this medication.

Frequently Asked Questions

Desvenlafaxine 50 mg is used to manage symptoms of mood disorders by affecting certain chemicals in the brain.

Desvenlafaxine 50 mg should be taken orally, typically once daily, with or without food. Do not crush or chew the extended-release tablets.

Common side effects may include nausea, dizziness, fatigue, dry mouth, and insomnia. These effects can vary from person to person.

It is generally advised to avoid alcohol while taking Desvenlafaxine 50 mg, as it may increase the risk of side effects.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.